Açil Yahya, Springer Ingo, Behrens Peter, Ullrich Klaus-Peter, Hedderich Juergen, Bruns Juergen
Department of Oral and Maxillofacial Surgery, University of Kiel, Kiel, Germany.
J Cancer Res Clin Oncol. 2003 Oct;129(10):583-8. doi: 10.1007/s00432-003-0470-6. Epub 2003 Aug 28.
Hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP) are markers of collagen absorption and LP is specific for collagen type I in bone. In the present study we evaluated the concentration of HP and LP in urine of patients with osteosarcoma ( n=20; age range 16-49 years) and chondrosarcoma ( n=15; age range 18-70 years). The values were compared with those obtained from 74 healthy controls (age range 16-83 years). The range and upper limit of normal values (HP(max) and LP(max)) were measured in our control group. High performance liquid chromatography (HPLC) was used to determine concentrations of HP and LP (nmol/mmol creatinine). The average urinary HP concentrations were significantly increased in patients with osteosarcoma ( p=0.001) and chondrosarcoma ( p<0.001), whereas HP remained within the normal range in approximately half of the patients. The average urinary LP concentrations were not increased in osteosarcoma and chondrosarcoma patients as compared with the control group. Further studies in a large group of patients are necessary to evaluate whether HP might be a valuable marker of prognosis, and if its urinary concentration can be correlated to tumour burden.
羟赖氨酸吡啶啉(HP)和赖氨酸吡啶啉(LP)是胶原蛋白吸收的标志物,且LP是骨中I型胶原蛋白的特异性标志物。在本研究中,我们评估了骨肉瘤患者(n = 20;年龄范围16 - 49岁)和软骨肉瘤患者(n = 15;年龄范围18 - 70岁)尿液中HP和LP的浓度。将这些值与74名健康对照者(年龄范围16 - 83岁)的值进行比较。在我们的对照组中测量了正常值的范围和上限(HP(max)和LP(max))。采用高效液相色谱法(HPLC)测定HP和LP的浓度(nmol/mmol肌酐)。骨肉瘤患者(p = 0.001)和软骨肉瘤患者(p < 0.001)的尿HP平均浓度显著升高,而约一半患者的HP仍在正常范围内。与对照组相比,骨肉瘤和软骨肉瘤患者的尿LP平均浓度没有升高。有必要对一大组患者进行进一步研究,以评估HP是否可能是一个有价值的预后标志物,以及其尿浓度是否与肿瘤负荷相关。